SCHEMBL3844075

SCHEMBL3844075

COc1ccc2c(c1)C=CCC(=O)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.44
GAA P10253 3/20 0.43
ACHE P22303 1/20 0.40
CYP19A1 P11511 3/20 0.39
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
DRD2 P14416 1/20 0.38
DRD1 P21728 1/20 0.38
DRD5 P21918 1/20 0.38
DRD3 P35462 1/20 0.38
MAOB P27338 1/20 0.38
CYP3A4 P08684 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10232028 0.87 GAA (0.57) METAP1GAAACHECYP19A1CYP11B1
SCHEMBL326339 0.83 DRD2 (0.41) METAP1GAAACHECYP19A1CYP11B1
SCHEMBL1143146 0.78 METAP1 (0.47) METAP1GAAACHECYP19A1CYP11B1
SCHEMBL12717984 0.77 BRD4 (0.54) GAAACHECYP3A4ALDH1A1KDM4E
SCHEMBL28569831 0.73 KDM4E (0.44) METAP1GAAACHECYP19A1MAOB
SCHEMBL4041676 0.73 METAP1 (0.58) METAP1GAAACHECYP19A1CYP11B1
SCHEMBL21335774 0.73 GAA (0.36) METAP1GAAACHECYP19A1CYP11B1
SCHEMBL30134456 0.73 MPO (0.42) METAP1CYP11B2DRD2DRD1DRD5
SCHEMBL9577946 0.73 CYP19A1 (0.42) METAP1GAAACHECYP19A1CYP11B1
SCHEMBL1478437 0.73 MPO (0.42) METAP1CYP11B2DRD2DRD1DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048126-A1 Benzocycloheptane derivatives as selectively active oestrogens Bayer Schering Pharma AG (DE) 2009-04-15 EP disclosed